Aurobindo Pharma Ltd. – (NSE: AUROPHARMA) Share Price Targets or Stock Price Targets, Future Prediction, Prognosis, Forecast for 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2033, 2035, 2037, 2040, 2042, 2047, 2050.
Long Term AUROPHARMA Share Price Targets for 2047
Aurobindo Pharma ltd. Share Price Targets in the Next 1, 3, 5, 7, and 10 Years.
YEARLY SHARE PRICE TARGETS |
| |
2024 | ₹815.76 |
2025 | ₹1,036.76 |
2026 | ₹1,234.33 |
2027 | ₹1,431.89 |
2028 | ₹1,719.86 |
2029 | ₹2,071.45 |
2030 | ₹2,523.50 |
2033 | ₹3,106.14 |
2035 | ₹3,297.00 |
2038 | ₹3,745.70 |
2040 | ₹4,140.82 |
2042 | ₹4,497.44 |
2045 | ₹5,132.65 |
2047 | ₹5,656.86 |
2050 | ₹6,257.08 |
Aurobindo Pharma Ltd. (AUROPHARMA) Share Price prediction for 2025
UP SIDE SHARE PRICE TARGETS |
| |
Target Lvl. 01 | ₹1,035.53 |
Target Lvl. 02 | ₹1,051.68 |
Target Lvl. 03 | ₹1,067.96 |
Target Lvl. 04 | ₹1,084.36 |
Target Lvl. 05 | ₹1,100.89 |
Target Lvl. 06 | ₹1,117.54 |
Target Lvl. 07 | ₹1,134.32 |
Target Lvl. 08 | ₹1,151.22 |
| |
Target Lvl. 09 | ₹1,168.25 |
Target Lvl. 10 | ₹1,185.40 |
Target Lvl. 11 | ₹1,202.68 |
Target Lvl. 12 | ₹1,220.08 |
Target Lvl. 13 | ₹1,237.60 |
Target Lvl. 14 | ₹1,255.26 |
Target Lvl. 15 | ₹1,273.03 |
Target Lvl. 16 | ₹1,290.94 |
| |
Target Lvl. 17 | ₹1,308.96 |
Target Lvl. 18 | ₹1,327.12 |
Target Lvl. 19 | ₹1,345.39 |
Target Lvl. 20 | ₹1,363.80 |
Target Lvl. 21 | ₹1,382.32 |
Target Lvl. 22 | ₹1,400.98 |
Target Lvl. 23 | ₹1,419.75 |
Target Lvl. 24 | ₹1,438.66 |
DOWN SIDE SHARE PRICE TARGETS |
| |
Target Lvl. 01 | ₹1,003.60 |
Target Lvl. 02 | ₹987.82 |
Target Lvl. 03 | ₹972.17 |
Target Lvl. 04 | ₹956.64 |
Target Lvl. 05 | ₹941.24 |
Target Lvl. 06 | ₹925.96 |
Target Lvl. 07 | ₹910.81 |
Target Lvl. 08 | ₹895.78 |
| |
Target Lvl. 09 | ₹880.88 |
Target Lvl. 10 | ₹866.10 |
Target Lvl. 11 | ₹851.45 |
Target Lvl. 12 | ₹836.92 |
Target Lvl. 13 | ₹822.52 |
Target Lvl. 14 | ₹808.24 |
Target Lvl. 15 | ₹794.09 |
Target Lvl. 16 | ₹780.06 |
| |
Target Lvl. 17 | ₹766.16 |
Target Lvl. 18 | ₹752.38 |
Target Lvl. 19 | ₹738.73 |
Target Lvl. 20 | ₹725.20 |
Target Lvl. 21 | ₹711.80 |
Target Lvl. 22 | ₹698.52 |
Target Lvl. 23 | ₹685.37 |
Target Lvl. 24 | ₹672.34 |
Aurobindo Pharma Share Price Targets in 2024, 2025, 2026, 2027, 2028, 2030, 2032, 2035, 2040, 2045.
FIB LEVEL (LONG TERM) |
| |
Price Target-01 | ₹815.76 |
Price Target-02 | ₹949.70 |
Price Target-03 | ₹1,036.76 |
Price Target-04 | ₹1,234.33 |
Price Target-05 | ₹1,431.89 |
Price Target-06 | ₹1,502.21 |
Price Target-07 | ₹1,652.89 |
Price Target-08 | ₹1,719.86 |
Price Target-09 | ₹2,071.45 |
AUROPHARMA Stock Price Forecast for 2030 as per Gann Analytics Method.
We are aware that W.D Gann is one of the prominent stock traders.
GANN LEVEL (MID TERM) |
| |
Price Target-01 | ₹397.20 |
Price Target-02 | ₹606.48 |
Price Target-03 | ₹815.76 |
Price Target-04 | ₹1,025.04 |
Price Target-05 | ₹1,234.33 |
Price Target-06 | ₹1,443.61 |
Price Target-07 | ₹1,652.89 |
Price Target-08 | ₹1,862.17 |
Price Target-09 | ₹2,071.45 |
Price Target-10 | ₹2,280.73 |
Price Target-11 | ₹2,490.01 |
Price Target-12 | ₹2,699.29 |
Price Target-13 | ₹2,908.58 |
Price Target-14 | ₹3,117.86 |
Price Target-15 | ₹3,327.14 |
Price Target-16 | ₹3,536.42 |
Price Target-17 | ₹3,745.70 |
Gann technical analysis is popular methods for share price predictions. We are preparing chart for Gann Price levels for your future trading strategy.
Leave a Reply
You must be logged in to post a comment.